Correlation Between Synlogic and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Synlogic and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synlogic and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synlogic and VistaGen Therapeutics, you can compare the effects of market volatilities on Synlogic and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synlogic with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synlogic and VistaGen Therapeutics.
Diversification Opportunities for Synlogic and VistaGen Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Synlogic and VistaGen is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Synlogic and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Synlogic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synlogic are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Synlogic i.e., Synlogic and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Synlogic and VistaGen Therapeutics
Given the investment horizon of 90 days Synlogic is expected to generate 1.28 times more return on investment than VistaGen Therapeutics. However, Synlogic is 1.28 times more volatile than VistaGen Therapeutics. It trades about -0.02 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 150.00 in Synlogic on August 28, 2024 and sell it today you would lose (11.00) from holding Synlogic or give up 7.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Synlogic vs. VistaGen Therapeutics
Performance |
| Timeline |
| Synlogic |
| VistaGen Therapeutics |
Synlogic and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Synlogic and VistaGen Therapeutics
The main advantage of trading using opposite Synlogic and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synlogic position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.| Synlogic vs. AC Immune | Synlogic vs. Protara Therapeutics | Synlogic vs. Vaccinex | Synlogic vs. Monopar Therapeutics |
| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Histogen | VistaGen Therapeutics vs. Entera Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |